Why is Dr Reddy's Labs falling/rising?

As of 13-Aug, Dr Reddys Laboratories Ltd's stock price is rising, currently at 1,252.55, reflecting an increase of 31.95 (2.62%). The stock has shown a positive performance today, outperforming its sector by 1.13%, and has been on a consecutive gain streak for the last five days, with a total return of 4.63% during this period. Despite a decline of 9.83% over the past year, the company maintains strong long-term fundamentals, including a low debt-to-equity ratio and a healthy return on equity of 16.9. However, there are concerns regarding falling investor participation, as evidenced by a significant drop in delivery volume, which may impact future price movements.
In the broader market context, Dr Reddys Laboratories has outperformed the Sensex in the short term, with a 1-week return of +4.63% compared to a flat performance of -0.01% for the benchmark. While the stock has struggled over the longer term, with a year-to-date decline of 9.77% against the Sensex's gain of 3.07%, the high institutional holdings at 63.1% suggest confidence from more knowledgeable investors. This institutional backing, combined with the company's attractive valuation relative to its peers, may contribute to the recent upward price movement despite the overall market challenges.